Repeated Dose Phase I Study of FYU-981

NCT02348333 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: FYU-981, (Oral daily dosing for 7 days)
DRUG: Placebo, (Oral daily dosing for 7 days)

Sponsor

Fuji Yakuhin Co., Ltd.